» Articles » PMID: 9504517

Cerebral Oedema and Increased Intracranial Pressure in Chronic Liver Disease

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1998 Mar 21
PMID 9504517
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cerebral oedema is a cause of morbidity and mortality in fulminant hepatic failure but has not been well documented as a complication of chronic liver diseases. We report here the development of cerebral oedema and increased intracranial pressure in 12 patients with chronic liver disease.

Methods: Between July 1, 1987, and Dec 31, 1993, we studied 12 patients aged 29-67 years with end-stage chronic liver disease. All the patients had cirrhosis, portal hypertension, hypoprothrombinaemia, hepatic encephalopathy, and decreased serum concentrations of albumin (<25 g/L). During the study, the patients developed signs of increased intracranial pressure and had documented intracranial hypertension, cerebral oedema, or both. Intracranial hypertension was suspected on physical examination and confirmed by epidural catheters. We detected cerebral oedema by computed axial tomography of the head and necropsy of the brain when possible.

Findings: All the patients had intracranial hypertension and cerebral oedema. Two patients had successful treatment of cerebral hypertension with improvement of intracranial pressure such that orthotopic liver transplantation was undertaken. Both patients became neurologically normal after transplantation. Eight patients had only a transient response to treatment and died of cerebral oedema before a transplant could be done.

Interpretation: Cerebral oedema and increased intracranial pressure can occur in chronic liver disease and presents as neurological deterioration. Treatment guided by monitoring of intracranial pressure can lead to the reversal of intracranial hypertension, but in most patients cerebral oedema contributes to death or places them at too high a risk for liver transplantation.

Citing Articles

Role of Continuous Drainage of Tense Ascites in Peritoneal Dialysis: Mehandru/Masud Technique.

Mehandru S, Kaur S, Masud A, Rezkalla K, Khan Q, Singh P J Med Cases. 2024; 15(10):287-296.

PMID: 39328802 PMC: 11424101. DOI: 10.14740/jmc4056.


The Glymphatic System May Play a Vital Role in the Pathogenesis of Hepatic Encephalopathy: A Narrative Review.

Sepehrinezhad A, Larsen F, Ashayeri Ahmadabad R, Shahbazi A, Negah S Cells. 2023; 12(7).

PMID: 37048052 PMC: 10093707. DOI: 10.3390/cells12070979.


Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel.

Rajpurohit S, Musunuri B, Shailesh , Basthi Mohan P, Shetty S J Clin Exp Hepatol. 2022; 12(4):1200-1214.

PMID: 35814520 PMC: 9257922. DOI: 10.1016/j.jceh.2022.01.012.


Neurological monitoring and sedation protocols in the Liver Intensive Care Unit.

Mehtani R, Garg S, Kajal K, Soni S, Premkumar M Metab Brain Dis. 2022; 37(5):1291-1307.

PMID: 35460476 DOI: 10.1007/s11011-022-00986-7.


Non-Convulsive Status Epilepticus in Hepatic Encephalopathy: A Case Series and Review of the Literature.

Nguyen A, Butt M, Upadhyay S, Sheikh A, Shekhar R Eur J Case Rep Intern Med. 2022; 9(2):003179.

PMID: 35265552 PMC: 8900554. DOI: 10.12890/2022_003179.